Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of
Invasive lobular carcinoma (ILC) is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. It covers 10-15% of all breast cancer cases,
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer Medicine Information
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GIOTRIF CMI0140-04 Film-coated Tablets afatinib (as dimaleate) Consumer Medicine Information What is in this leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEMETREXED APOTEX POWDER FOR INJECTION Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information
Tapping into an ancient evolutionary survival mechanism, cancer cells enter into a sluggish, slow-dividing state to survive the harsh environment created by chemotherapy or other targeted agents. In
For women going through cancer treatment, the hair-loss process is a topic that gets a lot of attention. What is not talked about as much, however, is what
Blood cancer: Symptoms explained by healthcare professionals Rebecca Burton, 29, was expecting her third child in June 2019 when doctors told her the shocking news that she had
This story is part of Survivor's Guide, a series on navigating the impact of breast cancer through beauty and self-care. Losing your hair is just one side effect
Blogger, 27, whose ‘itchy skin’ turned out to be CANCER shares her top 10 tips on how patients can smile through gruelling chemotherapy (and they include turning up
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
